We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Methods Developed to Generate Normal Stem Cells from Patients with Mitochondrial Defects

By LabMedica International staff writers
Posted on 29 Jul 2015
Print article
Image: Researchers have generated disease-free stem cells from patients with mitochondrial disease that can be converted into any cell type including neuronal progenitors (left) or heart cells (right). These could potentially be used for future transplantation into patients (Photo courtesy of Salk Institute of Biological Studies).
Image: Researchers have generated disease-free stem cells from patients with mitochondrial disease that can be converted into any cell type including neuronal progenitors (left) or heart cells (right). These could potentially be used for future transplantation into patients (Photo courtesy of Salk Institute of Biological Studies).
A recent paper described two methods for converting cells from patients with mitochondrial defects into normal pluripotent stem cells that could be induced to differentiate into several different types of tissues.

Mutations in mitochondrial DNA (mtDNA) can cause fatal or severely debilitating disorders with limited treatment options. Clinical manifestations vary based on mutation type and the relative levels of mutant and normal mtDNA within each cell.

Investigators at the Salk Institute for Biological Studies (La Jolla, CA, USA) first described the situation of patients having both normal and mutated mtDNA. Skin cells from these patients could be turned into a population of stem cells, some with normal mtDNA and some with mutated mtDNA. It was then a simple matter to clone only the cells with normal mtDNA to form a population of normal pluripotent stem cells.

The other case centered on patients with few, if any cells with normal mtDNA. To solve this problem the investigators removed the nuclei of the patient's skin cells, which contain most of their genes, and transplanted them into donor egg cells with healthy mitochondria. The new egg cells were then used to generate healthy pluripotent stem cells.

Results published in the July 15, 2015, online edition of the journal Nature revealed that both reprogramming approaches offered complementary strategies for derivation of pluripotent stem cells containing exclusively normal mtDNA.

"Right now, there are no cures for mitochondrial diseases," said senior author Dr. Juan Carlos Izpisua Belmonte, professor of genetics at the Salk Institute. "Very recently, we have developed ways to prevent these diseases, so it was natural to next ask how we could treat them."

Related Links:

Salk Institute


Gold Member
Turnkey Packaging Solution
HLX
Unit-Dose Packaging solution
HLX
New
Automated Nucleic Acid Extractor
eLab
New
Incubator
HettCube 120

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Molecular Diagnostics

view channel
Image: The bowel cancer breakthrough could result in better treatment outcomes (Photo courtesy of 123RF)

New RNA Molecules Can Help Predict Bowel Cancer Return Recurrence

Colorectal cancer accounts for 10% of all cancer-related deaths worldwide and was ranked as the second most common cause of cancer death in the United States in 2022. Currently, clinicians face diagnostic... Read more

Hematology

view channel
Image: QScout CBC will give a complete blood count in 2 minutes from fingerstick or venous blood (Photo courtesy of Ad Astra Diagnostics)

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more

Microbiology

view channel
Image: The InfectoSynovia test has the potential to revolutionize the diagnosis of periprosthetic joint infection (Photo courtesy of 123RF)

High-Accuracy Bedside Test to Diagnose Periprosthetic Joint Infection in Five Minutes

Periprosthetic joint infection (PJI) represents a significant global issue that is worsening as the number of joint replacements increases due to aging populations. In the United States alone, the anticipated... Read more

Pathology

view channel
Image

AI-Based Method Shows Promise for Pathological Diagnosis of Hereditary Kidney Diseases

Alport syndrome is a hereditary kidney disorder characterized by kidney dysfunction, sensorineural hearing loss, and ocular abnormalities. Early in the disease, patients experience hematuria, which is... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.